Spine Center, Schulthess Klinik, Lengghalde 2, 8008, Zurich, Switzerland.
Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Eur Spine J. 2024 Apr;33(4):1360-1368. doi: 10.1007/s00586-024-08134-8. Epub 2024 Feb 21.
The aim of this study was to investigate the risks and outcomes of patients with long-term oral anticoagulation (OAC) undergoing spine surgery.
All patients on long-term OAC who underwent spine surgery between 01/2005 and 06/2015 were included. Data were prospectively collected within our in-house Spine Surgery registry and retrospectively supplemented with patient chart and administrative database information. A 1:1 propensity score-matched group of patients without OAC from the same time interval served as control. Primary outcomes were post-operative bleeding, wound complications and thromboembolic events up to 90 days post-surgery. Secondary outcomes included intraoperative blood loss, length of hospital stay, death and 3-month post-operative patient-rated outcomes.
In comparison with the control group, patients with OAC (n = 332) had a 3.4-fold (95%CI 1.3-9.0) higher risk for post-operative bleeding, whereas the risks for wound complications and thromboembolic events were comparable between groups. The higher bleeding risk was driven by a higher rate of extraspinal haematomas (3.3% vs. 0.6%; p = 0.001), while there was no difference in epidural haematomas and haematoma evacuations. Risk factors for adverse events among patients with OAC were mechanical heart valves, posterior neck surgery, blood loss > 1000 mL, age, female sex, BMI > 30 kg/m and post-operative PTT levels. At 3-month follow-up, most patients reported favourable outcomes with no difference between groups.
Although OAC patients have a higher risk for complications after spine surgery, the risk for major events is low and patients benefit similarly from surgery.
本研究旨在探讨长期口服抗凝(OAC)患者行脊柱手术后的风险和结局。
纳入 2005 年 1 月至 2015 年 6 月期间行脊柱手术且正在接受长期 OAC 治疗的所有患者。数据通过我们内部脊柱手术登记系统前瞻性收集,并结合患者病历和行政数据库信息进行回顾性补充。同一时期未接受 OAC 治疗的患者按 1:1 倾向评分匹配作为对照组。主要结局为术后出血、伤口并发症和术后 90 天内的血栓栓塞事件。次要结局包括术中失血量、住院时间、死亡和术后 3 个月患者自评结局。
与对照组相比,接受 OAC 治疗的患者(n=332)术后出血风险高 3.4 倍(95%CI 1.3-9.0),而两组间伤口并发症和血栓栓塞事件的风险相当。较高的出血风险归因于脊柱外血肿发生率较高(3.3%比 0.6%;p=0.001),而硬膜外血肿和血肿清除术的发生率没有差异。OAC 患者不良事件的危险因素包括机械性心脏瓣膜、颈部后路手术、失血量>1000ml、年龄、女性、BMI>30kg/m²和术后 PTT 水平。在 3 个月随访时,大多数患者报告结局良好,两组间无差异。
尽管 OAC 患者脊柱手术后并发症风险较高,但主要事件风险较低,且患者从手术中获益相同。